Researchers assessed Smith (Sm)-specific regulatory T cells (Tregs) efficacy in halting lupus nephritis (LN) by engineering and testing epitope-targeted Tregs for systemic lupus erythematosus (SLE) treatment.
ADC startup raises €30M; Cyrus Biotechnology to spin out Levitate Bio
Plus, news about ProKidney: ADC makers return with new startup: Adcytherix raised €30 million ($32.1 million) in a seed round to … Sign up to